↓ Skip to main content

A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer

Overview of attention for article published in Redox Biology, October 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#3 of 2,687)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
24 news outlets
blogs
4 blogs
twitter
301 X users
facebook
2 Facebook pages
reddit
6 Redditors
video
1 YouTube creator
bluesky
10 Bluesky users
podcasts
2 podcasts

Readers on

mendeley
58 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer
Published in
Redox Biology, October 2024
DOI 10.1016/j.redox.2024.103375
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 301 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 58 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 58 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 6 10%
Other 4 7%
Student > Doctoral Student 3 5%
Student > Postgraduate 3 5%
Lecturer 2 3%
Other 8 14%
Unknown 32 55%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 11 19%
Biochemistry, Genetics and Molecular Biology 7 12%
Nursing and Health Professions 2 3%
Unspecified 1 2%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 2 3%
Unknown 34 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 415. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2026.
All research outputs
#90,051
of 34,539,236 outputs
Outputs from Redox Biology
#3
of 2,687 outputs
Outputs of similar age
#1,164
of 344,879 outputs
Outputs of similar age from Redox Biology
#1
of 54 outputs
Altmetric has tracked 34,539,236 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,687 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,879 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.